Skip to main content
Premium Trial:

Request an Annual Quote

In Rebranding Effort, Genstruct Changes Name to Selventa, Emphasizes Focus on Partnerships

Premium

Genstruct said this week that it has changed its name to Selventa as part of "an entire corporate rebranding effort" intended to emphasize its role as a data-analysis partner for drug developers and other clients.

The privately held company was founded in 2002 under the name Genstruct with a focus on using systems biology approaches to help customers discover biomarkers for personalized medicine.

In addition to the name change, Selventa this week reiterated its plans to focus on providing consulting services and software products, and to work with clients to select patient-specific treatments.

Diane Song, Selventa's marketing and scientific development manager, told BioInform via e-mail that the company is extending its consulting services by "offering software analytics and strategic partnering" with its clients, which she described as a "more focused business model" than the company had previously.

Specifically, the company said it plans to "embrace a customer-focused approach" that relies on existing patient data and "innovative analytics" to help drug developers "clarify decisions on therapeutics and diagnostics."

David de Graaf, chief scientific officer, said in a statement that the company's "new business strategy enables us to partner with clients at a deeper level to help them solve project portfolio development challenges and make a bigger impact on drug discovery."

He added that the new name, which comes from the Finnish selventää, which means "to clarify," reflects the company's "new focused approach."

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.